Profound Medical announces pricing of up to $40 million financing
Source: SeekingAlpha
2025-12-19 09:15:30 ET
More on Profound Medical Corp.
- Profound Medical Corp. (PRN:CA) Q3 2025 Earnings Call Transcript
- Profound Medical: Expectations Worsen
- Seeking Alpha’s Quant Rating on Profound Medical Corp.
- Historical earnings data for Profound Medical Corp.
- Financial information for Profound Medical Corp.
Read the full article on Seeking Alpha
For further details see:
Profound Medical announces pricing of up to $40 million financing
Profound Medical Corp.
NASDAQ: PRN:CC
PRN:CC Trading
0.45% G/L:
$11.28 Last:
9,800 Volume:
$11.23 Open:
PRN:CC Latest News
March 13, 2026 10:30:00 am
CAPTAIN Trial Comparing Profound's MRI-Guided TULSA Procedure(TM) to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
March 09, 2026 08:30:00 am
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
March 05, 2026 04:05:00 pm
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results
